BROOKS AUTOMATION, INC. (NASDAQ:BRKS) Files An 8-K Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits
|
(a) |
Financial Statements of Businesses Acquired. |
The audited consolidated financial statements of GENEWIZ Group as of December 31, 2017 and 2016 and for each of three years in the period ended December 31, 2017 together with the accompanying Report of Independent Auditors, are set forth in Exhibit 99.1.
The unaudited consolidated financial statements of GENEWIZ Group as of September 30, 2018 and for the nine months ended September 30, 2018 and 2017, are set forth in Exhibit 99.2.
|
(b) |
Unaudited Pro Forma Financial Information |
The unaudited pro forma condensed combined financial statements for the Company and GENEWIZ as of and for the year ended September 30, 2018, are set forth in Exhibit 99.3.
(d) Exhibits
The following exhibits are filed with this Current Report on Form 8-K/A.
BROOKS AUTOMATION INC Exhibit
EX-23.1 2 brks-20181115ex231737c25.htm EX-23.1 brks_20190124_Ex23_1 Exhibit 23.1 Consent of Independent Auditors We consent to the use of our report dated November 13,…
To view the full exhibit click here
About BROOKS AUTOMATION, INC. (NASDAQ:BRKS)
Brooks Automation, Inc. is a provider of automation and cryogenic solutions for various applications and markets. The Company operates through two segments: Brooks Semiconductor Solutions Group and Brooks Life Science Systems. The Brooks Semiconductor Solutions Group segment offers critical automated transport, vacuum and contamination controls solutions and services. Its product offerings include robots and integrated automation systems for handling of substrates. It is also a provider of cryogenic components to create vacuum and thermal stability within critical operating environments in the manufacturing process. It also offers equipment for automated contamination control, conditioning and metrology solutions for wafer and reticle carriers. The Brooks Life Science Systems segment offers sample life cycle management solutions that provide life science and bioscience customers with a range of sample management solutions for scientific research and support drug development.